-
公开(公告)号:US09205100B2
公开(公告)日:2015-12-08
申请号:US14002660
申请日:2012-03-01
申请人: Andrew E. Gelman , Elena Feinstein , Svetlana Adamsky , Igor Mett , Hagar Kalinski , Sharon Avkin-Nachum
发明人: Andrew E. Gelman , Elena Feinstein , Svetlana Adamsky , Igor Mett , Hagar Kalinski , Sharon Avkin-Nachum
IPC分类号: C12N15/11 , A61K31/713 , C12N15/113
CPC分类号: C12N15/113 , A61K31/713 , C12N15/1138 , C12N2310/11 , C12N2310/14 , C12N2310/321 , C12N2310/344 , C12N2310/3521
摘要: Disclosed herein are therapeutic methods for treating lung diseases, disorders and injury in a mammal, including treatment of acute respiratory distress syndrome (ARDS), acute lung injury, pulmonary fibrosis (idiopathic), bleomycin induced pulmonary fibrosis, mechanical ventilator induced lung injury, chronic obstructive pulmonary disease (COPD), chronic bronchitis, emphysema, bronchiolitis obliterans after lung transplantation and lung transplantation-induced acute graft dysfunction, including treatment, prevention or prevention of progression of primary graft failure, ischemia-reperfusion injury, reperfusion injury, reperfusion edema, allograft dysfunction, pulmonary reimplantation response, bronchiolitis obliterans after lung transplantation and/or primary graft dysfunction (PGD) after organ transplantation, in particular in lung transplantation, comprising downregulating the TLR2 gene or both the TLR2 gene and TLR4 gene. Provided herein are compositions, methods and kits for treating lung diseases, disorders and injury.
摘要翻译: 本文公开了治疗哺乳动物肺疾病,病症和损伤的治疗方法,包括治疗急性呼吸窘迫综合征(ARDS),急性肺损伤,肺纤维化(特发性),博来霉素诱导的肺纤维化,机械通气机诱导的肺损伤,慢性 阻塞性肺疾病(COPD),慢性支气管炎,肺气肿,肺移植后闭塞性细支气管炎和肺移植引起的急性移植物功能障碍,包括治疗,预防或预防原发性移植物衰竭,缺血再灌注损伤,再灌注损伤,再灌注水肿, 同种异体移植功能障碍,肺再植入反应,肺移植后闭塞性细支气管炎和/或器官移植后特别是肺移植中的原发性移植物功能障碍(PGD),包括下调TLR2基因或TLR2基因和TLR4基因。 本文提供了用于治疗肺部疾病,病症和损伤的组合物,方法和试剂盒。
-
公开(公告)号:US20200164032A1
公开(公告)日:2020-05-28
申请号:US16608672
申请日:2018-04-27
申请人: Daved Fremont , Olga Lubman , Andrew E. Gelman , Yun Hsuan Lu
发明人: Daved Fremont , Olga Lubman , Andrew E. Gelman , Yun Hsuan Lu
IPC分类号: A61K38/17
摘要: The present disclosure generally provides compositions and methods related to the field of immunology. Specifically, disclosed herein are chemokine binding proteins and methods of use thereof.
-
公开(公告)号:US20090220528A1
公开(公告)日:2009-09-03
申请号:US11922443
申请日:2006-06-15
申请人: Laurence Turka , Andrew E. Gelman
发明人: Laurence Turka , Andrew E. Gelman
IPC分类号: A61K39/395 , A61K31/711 , A61K39/00 , A61K35/12 , C12N5/10 , C12N5/06 , A61P37/02
CPC分类号: C07K16/2851 , C07K16/2809 , C07K2317/75
摘要: The present invention relates to compositions and methods for modulating Toll-like receptors (TLRs) for enhancing survival of activated CD4+ T cells. The enhanced survival of activated CD4+ T cells provides a means for regulating an immune response.
摘要翻译: 本发明涉及调节Toll样受体(TLR)以增强活化的CD4 + T细胞存活的组合物和方法。 活化的CD4 + T细胞的增强的存活提供了调节免疫应答的手段。
-
4.
公开(公告)号:US5441739A
公开(公告)日:1995-08-15
申请号:US29896
申请日:1993-03-11
IPC分类号: G01N33/543 , A61J1/05 , A61K9/00 , A61K9/127 , A61K9/51 , A61K38/00 , A61K38/28 , A61K38/40 , A61K38/42 , A61K38/48 , A61K39/12 , A61K39/21 , A61K47/26 , A61K47/48 , A61K48/00 , A61L27/00 , A61L31/10 , A61L33/00 , C07K14/05 , C07K14/16 , C09D201/00 , C12N11/14 , C12N15/87 , G01N27/447
CPC分类号: B82Y5/00 , A61K47/26 , A61K47/48861 , A61K47/48884 , A61K48/00 , A61K9/0019 , A61K9/0026 , A61K9/127 , A61K9/5115 , A61K9/5161 , A61L31/10 , C07K14/005 , C12N11/14 , C12N15/87 , C12N2710/16222 , C12N2740/16022
摘要: Articles of manufacture which are adapted for use in contact with one or more biologically active agents are coated with a glassy carbohydrate film. The glassy film provides a reduced surface energy coating which exhibits a reduced degree of binding with biologically active agents. Methods for applying the glassy carbohydrate film are disclosed wherein the glassy film is adsorbed directly onto the article surface. The coated articles are for use both in vitro and in vivo where contact with biologically active agents is expected.
摘要翻译: 适于与一种或多种生物活性剂接触使用的制品被玻璃状碳水化合物膜包覆。 玻璃状膜提供减少的表面能涂层,其表现出与生物活性剂的结合程度降低。 公开了应用玻璃状碳水化合物膜的方法,其中玻璃质膜直接吸附在制品表面上。 涂层制品在体外和体内都可用于与生物活性剂接触的预期。
-
公开(公告)号:US5464634A
公开(公告)日:1995-11-07
申请号:US232756
申请日:1994-04-25
IPC分类号: A61K9/50 , A61K9/00 , A61K9/127 , A61K9/18 , A61K9/51 , A61K31/00 , A61K38/42 , A61K39/12 , A61K39/21 , A61K47/26 , A61L31/10 , A61P7/00 , A61P7/08 , C07K14/05 , A61K9/16
CPC分类号: A61K9/0026 , A61K38/42 , A61K47/26 , A61K9/0019 , A61K9/127 , A61K9/5115 , A61K9/5161 , A61L31/10 , C07K14/005 , A61K2039/60 , Y10S514/832
摘要: A red blood cell surrogate which is composed of a nanocrystalline core particle to which an oxygen carrier such as hemoglobin is bound. An oxygen carrier anchor coating is provided between the nanocrystalline core particle and the oxygen carrier in order to provide binding of the oxygen carrier to the nanocrystalline core particle without denaturing the oxygen carrier or otherwise destroying its oxygen carrying capacity. The nanocrystalline core particle with the oxygen carrier bound thereto is coated with a layer of lipid and then an outer layer of a sugar or allosteric effector is applied.
摘要翻译: 由血红蛋白等氧载体结合的纳米晶核粒子构成的红细胞替代物。 在纳米晶核颗粒和氧载体之间提供氧载体锚固涂层,以便提供氧载体与纳米晶核颗粒的结合,而不使氧载体变性或以其它方式破坏其承载能力。 与其结合的氧载体的纳米晶核心颗粒涂覆有脂质层,然后施加糖或变构效应物的外层。
-
公开(公告)号:US5334394A
公开(公告)日:1994-08-02
申请号:US199
申请日:1993-01-04
IPC分类号: A61K9/00 , A61K9/127 , A61K9/51 , A61K38/00 , A61K38/28 , A61K38/40 , A61K38/42 , A61K38/48 , A61K39/12 , A61K39/21 , A61K47/26 , A61K47/48 , A61K48/00 , A61L31/10 , A61P31/12 , A61P31/18 , C07K14/05 , C07K14/16 , C12N11/14 , C12N15/87 , A61K9/14
CPC分类号: A61K39/21 , A61K39/12 , A61K47/26 , A61K47/48861 , A61K48/00 , A61K9/0019 , A61K9/0026 , A61K9/127 , A61K9/5115 , A61K9/5161 , A61L31/10 , B82Y5/00 , C07K14/005 , C12N11/14 , C12N15/87 , A61K2039/53 , A61K2039/545 , A61K2039/55566 , A61K2039/60 , C12N2710/16222 , C12N2710/16234 , C12N2740/16022 , C12N2740/16034 , Y10S514/934
摘要: A biologically active composition made up of core particles having diameters of less than about 1000 nanometers which are coated with a layer which is designed to allow attachment of biologically active proteins, peptides or pharmacological agents to the microparticles. When Human Immunodeficiency Virus (HIV) viral protein is attached to the core particles, the result is a viral decoy which accurately mimics native HIV in size, structure and surface character while being entirely devoid of virulent activity due to the microparticle core. The HIV decoy is useful as a vaccine for treating mammals to elicit an immune response.
摘要翻译: 由直径小于约1000纳米的核心颗粒组成的生物活性组合物,其被涂覆有被设计成允许生物活性蛋白质,肽或药理学试剂附着于微粒的层。 当人类免疫缺陷病毒(HIV)病毒蛋白连接到核心颗粒时,结果是一种病毒诱饵,其在大小,结构和表面特征上准确地模拟本地HIV,同时完全没有由于微粒核心的毒性活性。 HIV诱饵可用作治疗哺乳动物以引发免疫应答的疫苗。
-
公开(公告)号:US5306508A
公开(公告)日:1994-04-26
申请号:US29773
申请日:1993-03-11
IPC分类号: A61K9/50 , A61K9/00 , A61K9/127 , A61K9/16 , A61K9/51 , A61K31/00 , A61K31/70 , A61K31/74 , A61K31/785 , A61K33/44 , A61K38/00 , A61K38/16 , A61K38/28 , A61K38/40 , A61K38/42 , A61K38/48 , A61K39/12 , A61K39/21 , A61K47/26 , A61K47/48 , A61K48/00 , A61L31/10 , A61P7/08 , C07K14/05 , C07K14/16 , C12N11/14 , C12N15/87 , A61K9/14
CPC分类号: A61K9/0026 , A61K38/42 , A61K47/26 , A61K47/48861 , A61K47/48884 , A61K48/00 , A61K9/0019 , A61K9/127 , A61K9/5115 , A61K9/5161 , A61L31/10 , B82Y5/00 , C07K14/005 , C12N11/14 , C12N15/87 , C12N2710/16222 , C12N2740/16022 , Y10S514/814 , Y10S514/832 , Y10S514/833
摘要: A red blood cell surrogate which is composed of a nanocrystalline core particle to which an oxygen carrier such as hemoglobin is bound. An oxygen carrier anchor coating is provided between the nanocrystalline core particle and the oxygen carrier in order to provide binding of the oxygen carrier to the nanocrystalline core particle without denaturing the oxygen carrier or otherwise destroying its oxygen carrying capacity. The nanocrystalline core particle with the oxygen carrier bound thereto is coated with an exterior layer of lipid.
摘要翻译: 由血红蛋白等氧载体结合的纳米晶核粒子构成的红细胞替代物。 在纳米晶核颗粒和氧载体之间提供氧载体锚固涂层,以便提供氧载体与纳米晶核颗粒的结合,而不使氧载体变性或以其它方式破坏其承载能力。 具有与其结合的氧载体的纳米晶核心颗粒涂覆有外部脂质层。
-
公开(公告)号:US20140005253A1
公开(公告)日:2014-01-02
申请号:US14002660
申请日:2012-03-01
申请人: Andrew E. Gelman , Elena Feinstein , Svetlana Adamsky , Igor Mett , Hagar Kalinski , Sharon Avkin-Nachum
发明人: Andrew E. Gelman , Elena Feinstein , Svetlana Adamsky , Igor Mett , Hagar Kalinski , Sharon Avkin-Nachum
IPC分类号: A61K31/713
CPC分类号: C12N15/113 , A61K31/713 , C12N15/1138 , C12N2310/11 , C12N2310/14 , C12N2310/321 , C12N2310/344 , C12N2310/3521
摘要: Disclosed herein are therapeutic methods for treating lung diseases, disorders and injury in a mammal, including treatment of acute respiratory distress syndrome (ARDS), acute lung injury, pulmonary fibrosis (idiopathic), bleomycin induced pulmonary fibrosis, mechanical ventilator induced lung injury, chronic obstructive pulmonary disease (COPD), chronic bronchitis, emphysema, bronchiolitis obliterans after lung transplantation and lung transplantation-induced acute graft dysfunction, including treatment, prevention or prevention of progression of primary graft failure, ischemia-reperfusion injury, reperfusion injury, reperfusion edema, allograft dysfunction, pulmonary reimplantation response, bronchiolitis obliterans after lung transplantation and/or primary graft dysfunction (PGD) after organ transplantation, in particular in lung transplantation, comprising downregulating the TLR2 gene or both the TLR2 gene and TLR4 gene. Provided herein are compositions, methods and kits for treating lung diseases, disorders and injury.
摘要翻译: 本文公开了治疗哺乳动物肺疾病,病症和损伤的治疗方法,包括治疗急性呼吸窘迫综合征(ARDS),急性肺损伤,肺纤维化(特发性),博来霉素诱导的肺纤维化,机械通气机诱导的肺损伤,慢性 阻塞性肺疾病(COPD),慢性支气管炎,肺气肿,肺移植后闭塞性细支气管炎和肺移植引起的急性移植物功能障碍,包括治疗,预防或预防原发性移植物衰竭,缺血再灌注损伤,再灌注损伤,再灌注水肿, 同种异体移植功能障碍,肺再植入反应,肺移植后闭塞性细支气管炎和/或器官移植后特别是肺移植中的原发性移植物功能障碍(PGD),包括下调TLR2基因或TLR2基因和TLR4基因。 本文提供了用于治疗肺部疾病,病症和损伤的组合物,方法和试剂盒。
-
9.
公开(公告)号:US5639505A
公开(公告)日:1997-06-17
申请号:US448042
申请日:1995-05-23
IPC分类号: G01N33/543 , A61J1/05 , A61K9/00 , A61K9/127 , A61K9/51 , A61K38/00 , A61K38/28 , A61K38/40 , A61K38/42 , A61K38/48 , A61K39/12 , A61K39/21 , A61K47/26 , A61K47/48 , A61K48/00 , A61L27/00 , A61L31/10 , A61L33/00 , C07K14/05 , C07K14/16 , C09D201/00 , C12N11/14 , C12N15/87 , G01N27/447 , B05D5/08 , B05D3/00
CPC分类号: B82Y5/00 , A61K47/26 , A61K47/48861 , A61K47/48884 , A61K48/00 , A61K9/0019 , A61K9/0026 , A61K9/127 , A61K9/5115 , A61K9/5161 , A61L31/10 , C07K14/005 , C12N11/14 , C12N15/87 , C12N2710/16222 , C12N2740/16022
摘要: Articles of manufacture which are adapted for use in contact with one or more biologically active agents are coated with a glassy carbohydrate film. The glassy film provides a reduced surface energy coating which exhibits a reduced degree of binding with biologically active agents. Methods for applying the glassy carbohydrate film are disclosed wherein the glassy film is adsorbed directly onto the article surface.The coated articles are for use both in vitro and in vivo where contact with biologically active agents is expected.
摘要翻译: 适于与一种或多种生物活性剂接触使用的制品被玻璃状碳水化合物膜包覆。 玻璃状膜提供减少的表面能涂层,其表现出与生物活性剂的结合程度降低。 公开了应用玻璃状碳水化合物膜的方法,其中玻璃质膜直接吸附在制品表面上。 涂层制品在体外和体内都可用于与生物活性剂接触的预期。
-
-
-
-
-
-
-
-